Camupepimut did not improve disease-free survival versus observation in pancreatic cancer in the randomized phase 2 AMPLIFY-7P trial
In a randomized phase 2 trial, camupepimut did not improve disease-free survival versus observation in patients with resected KRAS-mutated pancreatic...
